GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Larson Financial Group LLC

Larson Financial Group LLC raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 223.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 3,142 shares of the company’s stock after purchasing an additional 2,170 shares during the period. Larson Financial Group LLC’s holdings in GE HealthCare Technologies were worth $295,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. Swedbank AB boosted its position in shares of GE HealthCare Technologies by 6.6% in the 3rd quarter. Swedbank AB now owns 72,013 shares of the company’s stock worth $6,758,000 after buying an additional 4,490 shares in the last quarter. CMG Global Holdings LLC raised its position in GE HealthCare Technologies by 2.3% during the third quarter. CMG Global Holdings LLC now owns 11,824 shares of the company’s stock worth $1,110,000 after acquiring an additional 271 shares during the last quarter. Kingsview Wealth Management LLC lifted its holdings in shares of GE HealthCare Technologies by 5.4% in the third quarter. Kingsview Wealth Management LLC now owns 10,624 shares of the company’s stock valued at $997,000 after purchasing an additional 545 shares in the last quarter. Cerity Partners LLC increased its stake in shares of GE HealthCare Technologies by 24.2% during the 3rd quarter. Cerity Partners LLC now owns 67,896 shares of the company’s stock worth $6,372,000 after purchasing an additional 13,228 shares in the last quarter. Finally, Certified Advisory Corp raised its position in shares of GE HealthCare Technologies by 69.9% during the 3rd quarter. Certified Advisory Corp now owns 4,642 shares of the company’s stock worth $436,000 after purchasing an additional 1,910 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their target price for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Evercore ISI increased their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. Finally, BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a report on Wednesday, September 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $94.36.

GE HealthCare Technologies Stock Down 0.2 %

Shares of GEHC opened at $82.51 on Wednesday. GE HealthCare Technologies Inc. has a fifty-two week low of $66.39 and a fifty-two week high of $94.55. The company’s fifty day moving average is $88.27 and its two-hundred day moving average is $83.62. The firm has a market cap of $37.70 billion, a PE ratio of 22.67, a price-to-earnings-growth ratio of 2.95 and a beta of 1.24. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.06 by $0.08. The firm had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm’s quarterly revenue was up .9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.99 earnings per share. Analysts forecast that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s payout ratio is 3.30%.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.27% of the stock is owned by insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.